Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Kumar A, Soumerai JD, Abramson JS, Barnes JA, et al. Zanubrutinib, Obinutuzumab, and Venetoclax for First-Line Treatment of Mantle Cell Lymphoma with a TP53 Mutation. Blood 2024 Oct 22:blood.2024025563. doi: 10.1182/blood.2024025563.
PMID: 39437708


Privacy Policy